XML 72 R62.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Liabilities - 2027 Term Loan - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 01, 2024
Feb. 05, 2024
Apr. 30, 2024
Jun. 30, 2024
Sep. 30, 2024
Jan. 05, 2022
Debt Instrument [Line Items]            
Interest rate         13.30%  
Debt partial prepayment to be Made   $ 175,000        
Minimum net sales convenant level agreed to be maintained over past year   $ 125,000        
Outstanding amount paid off         $ 260,387  
Loss on debt extinguishment       $ 12,600 $ 12,630  
2027 Term Loans            
Debt Instrument [Line Items]            
Principal amount $ 250,000         $ 250,000
Interest rate         0.26161%  
Spread on variable rate         1.00%  
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]         us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember  
Partial prepayment of principal $ 175,000          
Outstanding amount paid off     $ 175,000      
2027 Term Loans | BioPharma Credit Investments V GP LLC            
Debt Instrument [Line Items]            
Principal amount         $ 300,000  
Funded amount         250,000  
Outstanding amount paid off         $ 79,600  
Prepayment premium percentage         3.00%  
Loss on debt extinguishment         $ 12,600  
2027 Term Loans | Starting April 1, 2023 | BioPharma Credit Investments V GP LLC            
Debt Instrument [Line Items]            
Stated interest rate         8.25%